Stay updated on De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Sign up to get notified when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.

Latest updates to the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded the keyword 'Squamous cell carcinoma of the head and neck' to the page's keyword/MeSH terms.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated the site revision to v3.5.0, replacing the previous revision v3.4.3.SummaryDifference0.0%

- Check29 days agoChange DetectedFooter revision label updated to v3.4.3; the previous v3.4.2 label was removed.SummaryDifference0.0%

- Check43 days agoChange DetectedAdded Oropharynx cancer as a topic and a Resources section linking to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision: v3.4.2 has been added to the page. Earlier entries, including a government funding notice and Revision: v3.4.1, appear to have been removed.SummaryDifference0.3%

- Check65 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

Stay in the know with updates to De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the De-Escalated Radiation + Nivolumab in P16+ Oropharynx Cancer Clinical Trial page.